Severity-Dependent Neuroaxonal Damage Assessed by Serum Neurofilaments in ICANS Patients Undergoing CD19-Targeted CAR T-Cell Therapy

by on 1 de desembre de 2025 with No hi ha comentaris
  • Vilaseca, A., Ariño, H., Iacoboni, G., Feijóo, S., Zabalza, A., Fissolo, N., Arévalo, M. J., Carpio, C., Sánchez, M., Tintoré, M., Comabella, M., Montalban, X., Barba, P., & Vidal-Jordana, Á. (2025). Severity-Dependent Neuroaxonal Damage Assessed by Serum Neurofilaments in ICANS Patients Undergoing CD19-Targeted CAR T-Cell Therapy. European Journal of Neurology, 32(8), e70305. https://doi.org/10.1111/ene.70305

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *